IJMSC Author Spotlight shines a light on the people behind the research.
Possible future applications of optogenetics in MS therapy include the induction of oligodendrocyte proliferation, myelin synthesis, enhancing the repair of demyelinating processes, and modulating the severity of MS symptoms.
Arterial stiffness is associated with aging, obesity, comorbidities, and cardiovascular disease in the general population and needs to be further studied in people with MS.